COVID-19

January 27, 2022

Chengappa Kavadichanda, MD, discusses his study, “Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network.”

January 27, 2022

From physical activity levels, to T-cell immune responses and quality of life, COVID-19 has impacted the lives of patients with rheumatic diseases. Take 5 minutes to catch up on the latest COVID-19 news.

January 18, 2022

Physical activity is known to improve function, quality of life, and pain in rheumatoid arthritis. How has the pandemic affected patients’ participation in physical activity? Test your knowledge with this quiz.

January 12, 2022

For patients with rheumatoid arthritis, reduced levels of PA may impact disease activity, increase the likelihood of obesity, and may even lead to more frequent hospitalizations.

January 06, 2022

While patients with rheumatoid arthritis on rituximab therapy have been reported to have insufficient serological responses to the COVID-19 vaccine, T cells, which protect against severe COVID-19, may be elevated after a third dose.

December 14, 2021

"Understanding the effects of the pandemic on specific areas of health care is crucial for future planning in both the immediate and longer term," stated investigators.

November 29, 2021

Paul R. Fortin, MD, MPH, FRCPC, discusses the impact of the COVID-19 vaccine in immunosuppressed adults and those with autoimmune diseases.

November 22, 2021

Courtney Wells, PhD, MPH, MSW, discusses the impact of the pandemic on the quality of life of patients with rheumatic conditions, with an emphasis on perceived risk and decision making.

November 18, 2021

Kelly Gavigan, MPH, discusses the changes in patient-reported outcome scores during the COVID-19 pandemic.

November 09, 2021

Investigators observed stark contrasts in COVID-19 mRNA vaccination response among inflammatory rheumatic disease patients and the general population.